Joining the Fight Against Diabetes - IHH Healthcare
  • Join our community
  • IHH@LinkedIn
  • IHH@Youtube
  • IHH@Facebook
Joining the Fight Against Diabetes
24 Jul 2023

According to the World Health Organization, about 422 million people worldwide have diabetes, and 1.5 million deaths are directly attributed to it each year. To better understand the nuances and factors contributing to the disease and its complications, IHH Malaysia became the first Platinum Sponsor of the Seremban Diabetes (SeDia) Cohort Study in Malaysia, with a contribution of RM 2 million.

Jean-François Naa, CEO of IHH Malaysia, presented a mock cheque at the launch of the longitudinal study by the Ministry of Health and International Medical University on 08 July 2023.

The SeDia Cohort Study will encompass a comprehensive examination of various factors, from genetics and family history of diabetes to lifestyle and environmental factors, dietary regimes, physical activity, socio-economic levels and healthcare delivery. By understanding the complex connections between these factors, the aim is to uncover optimal strategies for diabetes prevention and treatment.

Subsequently, this knowledge can be translated into evidence-based public healthcare policies and programmes that are relevant to the local community. This ensures the efficacy of developed treatment and prevention initiatives in addressing the escalating burden of diabetes in Malaysia.

This 12-year study marks the first important step towards obtaining data that is socio-culturally relevant to the local community. It involves over 5,000 patients registered as part of the Klinik Kesihatan Seremban’s Diabetes Registry and over 7,000 of their family members, to investigate the complex web of interactions that contribute to the development of diabetes and its complications.

Topics:

Brands:

Related Stories

Gleneagles Hospital Singapore showcased Enhanced Recovery After Surgery (ERAS®) programme at 12th ERAS® World Congress

Gleneagles Hospital Singapore is advancing surgical recovery through its adoption of the Enhanced Recovery After Surgery (ERAS) programme, recognised for its early implementation in Singapore’s private healthcare sector.

24 Jul 2023
Read More

Expanding Care in Europe with Acibadem Rotterdam

Acibadem continues to expand its presence in Europe with the opening of Acibadem International Medical Center Rotterdam, located in the heart of the city within the iconic Unilever building.
24 Jul 2023
Read More

Strengthening Cardiac Care Through Regional Knowledge Sharing

Gleneagles JPMC recently held outreach events in East Kalimantan, led by Chief Operating Officer Mr ‘Izzul Hamzi bin Haji Jomari, as part of its on-going cardiac knowledge sharing sessions. 

24 Jul 2023
Read More

Gleneagles Hong Kong Supports Para Sports Development

Gleneagles Hong Kong continues to extend its care beyond healthcare by supporting initiatives that help build a more inclusive society.

24 Jul 2023
Read More

Climbing Kinabalu for Hope and Organ Donation Awareness

Mount Kinabalu is not an easy climb. For 35 transplant recipients, dialysis patients and members of the support team, taking on the mountain was more than a test of endurance. It was a powerful reminder that organ transplantation can give people the opportunity to live fuller, more active lives.
24 Jul 2023
Read More

Gleneagles Hospital Hong Kong Brings Preventive Care Closer to the Community

Gleneagles Health Day on 17 May focused on making everyday health knowledge more accessible, practical and engaging.

24 Jul 2023
Read More
HOSPITALS
PRIMARY CARE
ANCILLARY SERVICES
  • Acibadem Labmed Logo
  • Agilus Diagnostics Logo
  • Parkway Laboratories
  • Parkway Radiology Logo
  • Parkway Rehab Logo
  • Premier Integrated Labs Logo
  • Premier Integrated Rehab Logo